PCVX logo

Vaxcyte, Inc. (PCVX) Free Cash Flow

Annual FCF:

-$571.79M-$207.12M(-56.80%)
December 31, 2024

Summary

  • As of today, PCVX annual free cash flow is -$571.79 million, with the most recent change of -$207.12 million (-56.80%) on December 31, 2024.
  • During the last 3 years, PCVX annual free cash flow has fallen by -$443.84 million (-346.89%).
  • PCVX annual free cash flow is now -1673.53% below its all-time high of -$32.24 million, reached on December 31, 2018.

Performance

PCVX Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPCVXcash flow metrics

Quarterly FCF:

-$130.92M+$62.10M(+32.17%)
June 30, 2025

Summary

  • As of today, PCVX quarterly free cash flow is -$130.92 million, with the most recent change of +$62.10 million (+32.17%) on June 30, 2025.
  • Over the past year, PCVX quarterly free cash flow has increased by +$29.45 million (+18.37%).
  • PCVX quarterly free cash flow is now -1318.89% below its all-time high of -$9.23 million, reached on June 30, 2020.

Performance

PCVX Quarterly Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPCVXcash flow metrics

TTM FCF:

-$564.16M+$29.45M(+4.96%)
June 30, 2025

Summary

  • As of today, PCVX TTM free cash flow is -$564.16 million, with the most recent change of +$29.45 million (+4.96%) on June 30, 2025.
  • Over the past year, PCVX TTM free cash flow has increased by +$18.17 million (+3.12%).
  • PCVX TTM free cash flow is now -5666.17% below its all-time high of -$9.78 million, reached on March 31, 2019.

Performance

PCVX TTM Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPCVXcash flow metrics

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

PCVX Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-56.8%+18.4%+3.1%
3Y3 Years-346.9%-226.8%-268.0%
5Y5 Years-1082.8%-1318.9%-992.2%

PCVX Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-346.9%at low-232.4%+32.2%-247.1%+8.4%
5Y5-Year-1096.6%at low-1039.4%+32.2%-1080.7%+8.4%
All-TimeAll-Time-1673.5%at low-1318.9%+32.2%-5666.2%+8.4%

PCVX Free Cash Flow History

DateAnnualQuarterlyTTM
Jun 2025
-
-$130.92M(+32.2%)
-$564.16M(+5.0%)
Mar 2025
-
-$193.03M(-36.5%)
-$593.62M(-3.8%)
Dec 2024
-$571.79M(-56.8%)
-$141.43M(-43.2%)
-$571.79M(+7.2%)
Sep 2024
-
-$98.79M(+38.4%)
-$616.24M(-5.8%)
Jun 2024
-
-$160.37M(+6.3%)
-$582.34M(-20.7%)
Mar 2024
-
-$171.20M(+7.9%)
-$482.56M(-32.3%)
Dec 2023
-$364.67M(-106.7%)
-$185.88M(-186.5%)
-$364.67M(-48.8%)
Sep 2023
-
-$64.89M(-7.1%)
-$245.15M(-11.6%)
Jun 2023
-
-$60.60M(-13.7%)
-$219.65M(-10.3%)
Mar 2023
-
-$53.30M(+19.7%)
-$199.12M(-12.9%)
Dec 2022
-$176.44M
-$66.36M(-68.5%)
-$176.44M(-8.5%)
Sep 2022
-
-$39.39M(+1.7%)
-$162.55M(-6.0%)
Jun 2022
-
-$40.06M(-30.8%)
-$153.29M(-6.4%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$30.62M(+41.6%)
-$144.12M(-12.6%)
Dec 2021
-$127.95M(-167.8%)
-$52.48M(-74.1%)
-$127.95M(-47.1%)
Sep 2021
-
-$30.13M(+2.4%)
-$86.96M(-24.4%)
Jun 2021
-
-$30.89M(-113.7%)
-$69.91M(-44.9%)
Mar 2021
-
-$14.45M(-25.8%)
-$48.25M(-1.0%)
Dec 2020
-$47.78M(+1.2%)
-$11.49M(+12.2%)
-$47.78M(+7.5%)
Sep 2020
-
-$13.08M(-41.8%)
-$51.65M(-7.4%)
Jun 2020
-
-$9.23M(+34.0%)
-$48.09M(+8.5%)
Mar 2020
-
-$13.98M(+9.0%)
-$52.54M(-8.7%)
Dec 2019
-$48.34M(-49.9%)
-$15.36M(-61.4%)
-$48.34M(-46.6%)
Sep 2019
-
-$9.52M(+30.4%)
-$32.98M(-40.6%)
Jun 2019
-
-$13.68M(-39.8%)
-$23.46M(-139.8%)
Mar 2019
-
-$9.78M
-$9.78M
Dec 2018
-$32.24M
-
-

FAQ

  • What is Vaxcyte, Inc. annual free cash flow?
  • What is the all-time high annual free cash flow for Vaxcyte, Inc.?
  • What is Vaxcyte, Inc. annual free cash flow year-on-year change?
  • What is Vaxcyte, Inc. quarterly free cash flow?
  • What is the all-time high quarterly free cash flow for Vaxcyte, Inc.?
  • What is Vaxcyte, Inc. quarterly free cash flow year-on-year change?
  • What is Vaxcyte, Inc. TTM free cash flow?
  • What is the all-time high TTM free cash flow for Vaxcyte, Inc.?
  • What is Vaxcyte, Inc. TTM free cash flow year-on-year change?

What is Vaxcyte, Inc. annual free cash flow?

The current annual free cash flow of PCVX is -$571.79M

What is the all-time high annual free cash flow for Vaxcyte, Inc.?

Vaxcyte, Inc. all-time high annual free cash flow is -$32.24M

What is Vaxcyte, Inc. annual free cash flow year-on-year change?

Over the past year, PCVX annual free cash flow has changed by -$207.12M (-56.80%)

What is Vaxcyte, Inc. quarterly free cash flow?

The current quarterly free cash flow of PCVX is -$130.92M

What is the all-time high quarterly free cash flow for Vaxcyte, Inc.?

Vaxcyte, Inc. all-time high quarterly free cash flow is -$9.23M

What is Vaxcyte, Inc. quarterly free cash flow year-on-year change?

Over the past year, PCVX quarterly free cash flow has changed by +$29.45M (+18.37%)

What is Vaxcyte, Inc. TTM free cash flow?

The current TTM free cash flow of PCVX is -$564.16M

What is the all-time high TTM free cash flow for Vaxcyte, Inc.?

Vaxcyte, Inc. all-time high TTM free cash flow is -$9.78M

What is Vaxcyte, Inc. TTM free cash flow year-on-year change?

Over the past year, PCVX TTM free cash flow has changed by +$18.17M (+3.12%)
On this page